Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Diabetes|May 28, 2011
Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin toleranceHyun-Seuk Moon, Giuseppe Matarese, Aoife M Brennan, et al.
Biomedicines|January 21, 2023
Osteopontin Is Associated with Multiple Sclerosis RelapsesMario Stampanoni Bassi, Fabio Buttari, Luana Gilio, et al.
Metabolism: Clinical and Experimental|May 20, 2015
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetatePietro B Carrieri, Fortunata Carbone, Francesco Perna, et al.
Multiple Sclerosis and Related Disorders|January 29, 2023
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosisAntonio Bruno, Ettore Dolcetti, Federica Azzolini, et al.
Scientific Reports|July 30, 2024
Deciphering the role of protein kinase A in the control of FoxP3 expression in regulatory T cells in health and autoimmunityMaria Teresa Lepore, Sara Bruzzaniti, Claudia La Rocca, et al.
Journal of Clinical Medicine|January 18, 2020
Randomised Clinical Trial: Calorie Restriction Regimen with Tomato Juice Supplementation Ameliorates Oxidative Stress and Preserves a Proper Immune Surveillance Modulating Mitochondrial Bioenergetics of T-Lymphocytes in Obese Children Affected by Non-Alcoholic Fatty Liver Disease (NAFLD)Rossella Negri, Giovanna Trinchese, Fortunata Carbone, et al.
Metabolism: Clinical and Experimental|November 15, 2017
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respirationClaudia La Rocca, Fortunata Carbone, Veronica De Rosa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 5, 2019
Obesity worsens central inflammation and disability in multiple sclerosisMario Stampanoni Bassi, Ennio Iezzi, Fabio Buttari, et al.
Annals of Clinical and Translational Neurology|June 12, 2025
Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple SclerosisFortunata Carbone, Alessandra Colamatteo, Teresa Micillo, et al.
Clinical Immunology (Orlando, Fla.)|February 19, 2026
Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatmentClaudia Russo, Clorinda Fusco, Fortunata Carbone, et al.
Pageof 5